Katharine A. Price

Phase II Evaluation of Aggressive Dose De-Escalation for Adjuvant Chemoradiotherapy in Human Papillomavirus–Associated Oropharynx Squamous Cell Carcinoma

J. Daniel, Katharine A. Price, Eric J. Moore et al. · Journal of Clinical Oncology · 2019 · 226 citations · Full text

Medicine, Oncology, Radiation Oncology +11

Effect of Dobutamine on Oxygen Consumption and Gastric Mucosal pH in Septic Patients

Guillermo Gutiérrez, Cinda Clark, Steven Brown et al. · American Journal of Respiratory and Critical Care Medicine · 1994 · 192 citations

Veterinary Medicine, Pharmacology, Clinical Pharmacology +12

Precision Radiotherapy: Reduction in Radiation for Oropharyngeal Cancer in the 30 ROC Trial

Nadeem Riaz, Eric J. Sherman, Xin Pei et al. · JNCI Journal of the National Cancer Institute · 2020 · 160 citations · Full text

Medicine, Oncology, Radiation Oncology +9

NCCN Guidelines® Insights: Head and Neck Cancers, Version 2.2025

A. Dimitrios Colevas, Anthony J. Cmelak, David G. Pfister et al. · Journal of the National Comprehensive Cancer Network · 2025 · 133 citations

Medicine, Oncology, Radiation Oncology +17

A Phase 2 Study of Pembrolizumab Combined with Chemoradiotherapy as Initial Treatment for Anaplastic Thyroid Cancer

Ashish V. Chintakuntlawar, Jun Yin, Robert L. Foote et al. · Thyroid · 2019 · 80 citations

Medicine, Oncology, Pharmacotherapy +14